Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 283,445 | 0 |
| Marketable Securities | 143,501 | 0 |
| Receivables | 975 | 0 |
| Inventories | 602 | 0 |
| TOTAL | $428,573 | $0 |
| Non-Current Assets | ||
| PPE Net | 48 | 0 |
| Investments And Advances | 57,147 | 0 |
| Intangibles | 846 | 0 |
| TOTAL | $58,041 | $0 |
| Total Assets | $486,613 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 591 | 0 |
| Accrued Expenses | 1,499 | 0 |
| TOTAL | $7,622 | $0 |
| Non-Current Liabilities | ||
| Deferred Revenues | 1,040 | 0 |
| TOTAL | $0 | $0 |
| Total Liabilities | $7,622 | $0 |
| Shareholders' Equity | ||
| Common Shares | 341,065 | 0 |
| Retained earnings | 125,859 | 0 |
| Other shareholders' equity | 9,967 | 0 |
| TOTAL | $478,991 | $0 |
| Total Liabilities And Equity | $486,613 | $0 |